(Reuters) - GlaxoSmithKline (L:) said on Thursday it agreed to sell its entire stake in Unilever 's (L:) Indian business (NS:) for about 254.8 billion rupees ($3.35 billion) on the open market, cashing in late from the sale of the Horlicks brand. (https://reut.rs/3fvie8r)